Hematopoietic stem cell transplantation in the treatment of multiple myeloma

Multiple myeloma is a malignant clonal plasma cell disorder that accounts for about 10% of all hematological malignancies. Conventional melphalan-based chemotherapy produces less than 5% of complete remission rates, with less than 5% of patients surviving 10 years or more. The VAD regimen is very ef...

Full description

Bibliographic Details
Main Author: Angelo Maiolino
Format: Article
Language:English
Published: Elsevier 2002-01-01
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842002000300005&tlng=en